Vanguard Group Inc Ocugen, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,683,113 shares of OCGN stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,683,113
Previous 16,619,093
0.39%
Holding current value
$19.4 Million
Previous $13.3 Million
10.91%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OCGN
# of Institutions
118Shares Held
75.1MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$20.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$7.99 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$6.88 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$5.07 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.82 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $251M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...